haploid allogeneic NK cell therapy
DS2019070101
Phase 1 mab active
Quick answer
haploid allogeneic NK cell therapy for Acute Myeloid Leukemia is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 1
- Modality
- mab
- Status
- active